Johnson & Johnson
JNJ
$167.46
$0.470.28%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 10/01/2023 | 07/02/2023 | |
|---|---|---|---|---|---|
| Revenue | 22.45B | 21.38B | 21.40B | 21.35B | 21.52B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.45B | 21.38B | 21.40B | 21.35B | 21.52B |
| Cost of Revenue | 6.87B | 6.50B | 6.72B | 6.38B | 6.46B |
| Gross Profit | 15.58B | 14.88B | 14.68B | 14.97B | 15.06B |
| SG&A Expenses | 5.45B | 5.03B | 5.47B | 5.10B | 5.04B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.75B | 15.07B | 16.67B | 14.93B | 15.20B |
| Operating Income | 6.69B | 6.31B | 4.73B | 6.42B | 6.32B |
| Income Before Tax | 5.75B | 3.71B | 4.83B | 5.22B | 6.31B |
| Income Tax Expenses | 1.06B | 459.00M | 694.00M | 908.00M | 930.00M |
| Earnings from Continuing Operations | 4.69B | 3.26B | 4.13B | 4.31B | 5.38B |
| Earnings from Discontinued Operations | -- | -- | -83.00M | 21.72B | -232.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.69B | 3.26B | 4.05B | 26.03B | 5.14B |
| EBIT | 6.69B | 6.31B | 4.73B | 6.42B | 6.32B |
| EBITDA | 8.48B | 8.13B | 6.19B | 8.25B | 8.25B |
| EPS Basic | 1.95 | 1.35 | 1.46 | 10.32 | 1.98 |
| Normalized Basic EPS | 1.83 | 1.77 | 1.07 | 1.66 | 1.58 |
| EPS Diluted | 1.93 | 1.34 | 1.46 | 10.21 | 1.96 |
| Normalized Diluted EPS | 1.81 | 1.75 | 1.07 | 1.64 | 1.56 |
| Average Basic Shares Outstanding | 2.41B | 2.41B | 2.77B | 2.52B | 2.60B |
| Average Diluted Shares Outstanding | 2.42B | 2.43B | 2.77B | 2.55B | 2.63B |
| Dividend Per Share | 1.24 | 1.19 | 1.19 | 1.19 | 1.19 |
| Payout Ratio | 63.70% | 88.14% | 70.76% | -- | 60.11% |
